Carotid artery stenting - current status of the procedure
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10196256" target="_blank" >RIV/00064203:_____/13:10196256 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/13:10196256
Výsledek na webu
<a href="http://dx.doi.org/10.5114/aoms.2013.39216" target="_blank" >http://dx.doi.org/10.5114/aoms.2013.39216</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/aoms.2013.39216" target="_blank" >10.5114/aoms.2013.39216</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Carotid artery stenting - current status of the procedure
Popis výsledku v původním jazyce
Surgical carotid endarterectomy (CEA) was long considered the standard approach for the treatment of atherosclerotic carotid artery disease. This was based on results of several randomized trials demonstrating its effectiveness over the best medical therapy. In the past two decades, patients identified high-risk for surgery were offered carotid artery stenting (CAS) as a less invasive option. Despite its initial limitations, CAS has evolved into an elaborate method currently considered to be equivalentand in selected patients even preferable to CEA. However, outcomes of both procedures are highly operator dependent and a simple stratifying method to prioritize CAS, CEA or medical therapy only has not yet been proposed. In addition, recently publishedrandomized trials highlighted the importance of proper patient selection and rigorous training contributing to low absolute rates of (procedural) adverse events. This review discusses the history and evidence for carotid revascularization
Název v anglickém jazyce
Carotid artery stenting - current status of the procedure
Popis výsledku anglicky
Surgical carotid endarterectomy (CEA) was long considered the standard approach for the treatment of atherosclerotic carotid artery disease. This was based on results of several randomized trials demonstrating its effectiveness over the best medical therapy. In the past two decades, patients identified high-risk for surgery were offered carotid artery stenting (CAS) as a less invasive option. Despite its initial limitations, CAS has evolved into an elaborate method currently considered to be equivalentand in selected patients even preferable to CEA. However, outcomes of both procedures are highly operator dependent and a simple stratifying method to prioritize CAS, CEA or medical therapy only has not yet been proposed. In addition, recently publishedrandomized trials highlighted the importance of proper patient selection and rigorous training contributing to low absolute rates of (procedural) adverse events. This review discusses the history and evidence for carotid revascularization
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FA - Kardiovaskulární nemoci včetně kardiochirurgie
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NT13319" target="_blank" >NT13319: Vaskulární faktory v predikci rozvoje Alzheimerovy choroby.</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2013
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Archives of Medical Science
ISSN
1734-1922
e-ISSN
—
Svazek periodika
9
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
PL - Polská republika
Počet stran výsledku
7
Strana od-do
1028-1034
Kód UT WoS článku
000329768400010
EID výsledku v databázi Scopus
—